Oscar Health (NYSE:OSCR) Announces Quarterly Earnings Results

Oscar Health (NYSE:OSCR) released its quarterly earnings results on Thursday. The company reported ($0.53) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.55) by $0.02, Zacks reports. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 20.84%. The business had revenue of $2.93 billion for the quarter, compared to analyst estimates of $3.09 billion. During the same period in the previous year, the company earned ($0.22) earnings per share. The business’s revenue for the quarter was up 23.2% on a year-over-year basis. Oscar Health updated its FY 2025 guidance to EPS.

Oscar Health Stock Performance

Shares of OSCR stock traded up $1.14 during mid-day trading on Friday, reaching $17.70. The stock had a trading volume of 24,640,823 shares, compared to its average volume of 14,876,280. Oscar Health has a 1-year low of $11.20 and a 1-year high of $23.80. The firm has a market cap of $4.58 billion, a price-to-earnings ratio of -15.81 and a beta of 1.88. The company has a current ratio of 0.86, a quick ratio of 0.86 and a debt-to-equity ratio of 0.26. The business’s fifty day moving average is $19.17 and its 200-day moving average is $16.81.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on OSCR shares. Barclays dropped their target price on Oscar Health from $17.00 to $11.00 and set an “underweight” rating on the stock in a research note on Wednesday, July 23rd. Wells Fargo & Company raised their price target on Oscar Health from $10.00 to $14.00 and gave the stock an “underweight” rating in a report on Tuesday, October 7th. Robert W. Baird restated a “neutral” rating and set a $14.00 price target (down previously from $28.00) on shares of Oscar Health in a research note on Friday, July 25th. The Goldman Sachs Group began coverage on shares of Oscar Health in a research report on Tuesday, October 14th. They issued a “neutral” rating and a $17.00 price objective for the company. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Oscar Health in a research note on Wednesday, October 8th. Six investment analysts have rated the stock with a Hold rating and five have given a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Reduce” and a consensus price target of $13.29.

Insider Activity at Oscar Health

In related news, insider Mario Schlosser sold 395,000 shares of the company’s stock in a transaction that occurred on Monday, September 22nd. The stock was sold at an average price of $18.43, for a total value of $7,279,850.00. Following the sale, the insider owned 501,148 shares in the company, valued at $9,236,157.64. This represents a 44.08% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 24.39% of the stock is owned by company insiders.

Hedge Funds Weigh In On Oscar Health

Institutional investors have recently bought and sold shares of the business. Tower Research Capital LLC TRC increased its stake in shares of Oscar Health by 274.2% in the second quarter. Tower Research Capital LLC TRC now owns 30,499 shares of the company’s stock worth $654,000 after acquiring an additional 22,349 shares during the period. Sender Co & Partners Inc. acquired a new position in Oscar Health during the second quarter valued at $409,000. Tidal Investments LLC boosted its holdings in Oscar Health by 32.5% in the second quarter. Tidal Investments LLC now owns 43,010 shares of the company’s stock valued at $922,000 after purchasing an additional 10,557 shares during the last quarter. BNP Paribas Financial Markets boosted its holdings in Oscar Health by 42.5% in the second quarter. BNP Paribas Financial Markets now owns 26,151 shares of the company’s stock valued at $561,000 after purchasing an additional 7,804 shares during the last quarter. Finally, Marshall Wace LLP acquired a new stake in Oscar Health during the 2nd quarter worth about $626,000. 75.70% of the stock is owned by hedge funds and other institutional investors.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.